Lab Hotel
As part of SBC’s commitment to supporting early-stage start-ups, the Lab Hotel provides seven organisations with rent-free space for six months
The Lab Hotel
As part of our commitment to supporting early-stage start-ups, the Lab Hotel provides seven organisations with rent-free space for six months in the Incubator building.
The Lab Hotel offers each start-up access to two spaces in a laboratory which contains both molecular biology and mammalian tissue culture equipment.
In addition, each occupier is allocated two office desks and can use shared facilities including the Community Lab and the Cytiva Technology Lab.
Business support
Being part of the Lab Hotel provides young companies with access to mentoring and introductions to the right investors for their stage of their development.
They can also take advantage of SBC's meeting rooms, networks and events.
SBC’s Lab Hotel has been extremely helpful to us. It enabled us to work from a commercial, rather than university, setting which helped us to present our company as a professional entity and increased our understanding of an Incubator facility. The lab and offices are well equipped and it has been helpful to be able to interact with others in the cohort.
Ajay Mistry, PhD
founder and CEO of Oppilotech
Current and former occupiers
-
Genenet Technology
Genenet Technology (UK) Ltd integrates state-of-art deep learning neural networks into the gene circuit design. This unleashes the potential of genetic design into previously impossible applications.
Learn more -
Neobe is developing a platform for the engineering of programmable live biotherapeutics, which can colonize solid tumours and remodel their local microenvironment.
Learn more -
Inspira Pharmaceuticals is a preclinical biotech company developing proprietary plant-based enzymes for therapeutic applications. Their research is currently focussed on the treatment of respiratory biofilms and viral respiratory infections.
Learn more -
Ladder Therapeutics is an early stage AI enabled biotech combining in vitro assays and in silico models to discover small molecules targeting RNA.
Learn more -
ImmTune Therapies is developing gene delivery vectors for specific modification of immune cells inside a patient’s body, enabling an in vivo cell therapy process.
Learn more -
Nuntius Therapeutics is developing novel delivery vectors for DNA, RNA and CRISPR therapies to enable the delivery of large genetic payloads into the correct cells.
Learn more -
Stratosvir is developing viral immunotherapy which has the potential to drastically improve the clinical treatment of solid tumours and their metastases.
Learn more -
Oppilotech has developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells enabling them to identify viable drug targets and discover new biology.
Learn more -
Exogene is accelerating the discovery of T-cell-receptor (TCR)- based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening.
Learn more
How to apply for the Lab Hotel
Spaces become available on a six monthly basis and there is an application process for new occupiers. To register your interest in being considered for a pace, please email comms@stevenagecatalyst.com.
Selection criteria:
The Lab Hotel is open to start-ups that:
- are developing therapeutics
- have a wet-lab component
- have pre-series A funding in place
Find out more about the Lab Hotel
Apply hereCopyright © 2023 Stevenage Bioscience Catalyst
We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.